Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study
Annals of Nuclear Medicine · 2024
DOI: 10.1007/s12149-024-01936-2 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Annals of Nuclear Medicine, 2024. Verfasst von Kun-Han Lue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging and Radiological Sciences, Tzu Chi University of Science and Technology, No.880, Sec.2, Chien-kuo Rd., Hualien, 970302,…. Hauptthemen laut MEDLINE: ErbB Receptors, Fluorodeoxyglucose F18, Lung Neoplasms, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Buddhist Tzu Chi Medical Foundation, National Science and Technology Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging and Radiological Sciences, Tzu Chi University of Science and Technology, No.880, Sec.2, Chien-kuo Rd., Hualien, 970302, Taiwan.
- Department of Medical Imaging and Radiological Sciences, Tzu Chi University of Science and Technology, No.880, Sec.2, Chien-kuo Rd., Hualien, 970302, Taiwan. jedimasterchen@hotmail.com.
- Department of Nuclear Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No.707, Sec.3, Zhongyang Rd, Hualien, 970473, Taiwan. jedimasterchen@hotmail.com.
- School of Medicine, College of Medicine, Tzu Chi University, No.701, Sec.3, Zhongyang Rd, Hualien, 970473, Taiwan. jedimasterchen@hotmail.com.
- School of Medicine, College of Medicine, Tzu Chi University, No.701, Sec.3, Zhongyang Rd, Hualien, 970473, Taiwan.
- Department of Hematology and Oncology, Buddhist Tzu Chi Medical Foundation, Hualien Tzu Chi Hospital, Hualien, Taiwan.
Förderung
- Buddhist Tzu Chi Medical Foundation
- National Science and Technology Council
Zitieren
APA
Lue, K. H., Chen, Y. H., Chu, S. C., Lin, C. B., Wang, T. F., & Liu, S. H. (2024). Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-024-01936-2
Vancouver
Lue KH, Chen YH, Chu SC, Lin CB, Wang TF, Liu SH. Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study. Annals of Nuclear Medicine. 2024. doi:10.1007/s12149-024-01936-2
BibTeX
@article{Lue2024,
author = {Lue, Kun-Han and Chen, Yu-Hung and Chu, Sung-Chao and Lin, Chih-Bin and Wang, Tso-Fu and Liu, Shu-Hsin},
title = {Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study},
journal = {Annals of Nuclear Medicine},
year = {2024},
doi = {10.1007/s12149-024-01936-2}
}
EUVIMED